Journal of addiction medicine
Authors: Riley ED, Warner L, Hahn JA, Braun C, Dilworth S, Zevin B, Neilands TB, Weiser SD
Volume 14 of Issue 17 | Cancers
Authors: Wagner MJ, Hennessy C, Beeghly A, French B, Shah DP, Croessmann S, Vilar-Compte D, Ruiz-Garcia E, Ingham M, Schwartz GK, Painter CA, Chugh R, Fecher L, Park C, Zamulko O, Trent JC, Subbiah V, Khaki AR, Tachiki L, Nakasone ES, Loggers ET, Labaki C, Saliby RM, McKay RR, Ajmera A, Griffiths EA, Puzanov I, Tap WD, Hwang C, Tejwani S, Jhawar SR, Hayes-Lattin B, Wulff-Burchfield E, Kasi A, Reuben DY, Nagaraj G, Joshi M, Polimera H, Kulkarni AA, Esfahani K, Kwon DH, Paoluzzi L, Bilen MA, Durbin EB, Grivas P, Warner JL, Davis EJ, COVID-19 and Cancer Consortium
BACKGROUND
Patients with sarcoma often require individualized treatment strategies and are likely to receive aggressive immunosuppressive therapies, which may place them at higher risk for severe COVID-19. We aimed to describe demographics, risk factors, and outcomes for patients with sarcoma and COVID-19.
METHODS
We performed a retrospective cohort study of patients with sarcoma and COVID-19 reported to the COVID-19 and Cancer Consortium (CCC19) registry (NCT04354701) from 17 March 2020 to 30 September 2021. Demographics, sarcoma histologic type, treatments, and COVID-19 outcomes were analyzed.
RESULTS
of 281 patients, 49% ( = 139) were hospitalized, 33% ( = 93) received supplemental oxygen, 11% ( = 31) were admitted to the ICU, and 6% ( = 16) received mechanical ventilation. A total of 23 (8%) died within 30 days of COVID-19 diagnosis and 44 (16%) died overall at the time of analysis. When evaluated by sarcoma subtype, patients with bone sarcoma and COVID-19 had a higher mortality rate than patients from a matched SEER cohort (13.5% vs 4.4%). Older age, poor performance status, recent systemic anti-cancer therapy, and lung metastases all contributed to higher COVID-19 severity.
CONCLUSIONS
Patients with sarcoma have high rates of severe COVID-19 and those with bone sarcoma may have the greatest risk of death.
View on PubMed
The Lancet. Respiratory medicine
Authors: Conrad C, Looney MR
Journal of obesity & metabolic syndrome
Authors: Collins WJ, Chang AY, Weng Y, Dahlen A, O'Brien CG, Hom J, Ahuja N, Rodriguez F, Rohatgi N
Journal of women's health (2002)
Authors: Roubinov D, Haack LM, Folk JB, Rotenstein L, Accurso EC, Dahiya P, Ponce AN, Nava V, Maldonado Y, Linos E, Mangurian C
RMD open
Authors: DiIorio M, Kennedy K, Liew JW, Putman MS, Sirotich E, Sattui SE, Foster G, Harrison C, Larch? MJ, Levine M, Moni TT, Thabane L, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Gore-Massy M, Howard RA, Kodhek MA, Lalonde N, Tomasella LA, Wallace J, Akpabio A, Alp?zar-Rodr?guez D, Beesley RP, Berenbaum F, Bulina I, Chock EY, Conway R, Duarte-Garc?a A, Duff E, Gheita TA, Graef ER, Hsieh E, El Kibbi L, Liew DF, Lo C, Nudel M, Singh AD, Singh JA, Singh N, Ugarte-Gil MF, Hausmann JS, Simard JF, Sparks JA
RMD open
Authors: Yeoh SA, Gianfrancesco M, Lawson-Tovey S, Hyrich KL, Strangfeld A, Gossec L, Carmona L, Mateus EF, Sch?fer M, Richez C, Hachulla E, Holmqvist M, Scir? CA, Lorenz HM, Voll RE, Hasseli R, Jayatilleke A, Hsu TY, D'Silva KM, Pimentel-Quiroz VR, Vasquez Del Mercado M, Shinjo SK, Neto ETDR, Junior LFDR, de Oliveira E Silva Montandon AC, Pons-Estel GJ, Ornella S, D'Angelo Exeni ME, Velozo E, Jordan P, Sirotich E, Hausmann JS, Liew JW, Jacobsohn L, Gore-Massy M, Sufka P, Grainger R, Bhana S, Wallace Z, Robinson PC, Yazdany J, Machado PM, COVID-19 Global Rheumatology Alliance
The Lancet. Public health
Authors: Chen YH, Riley AR, Duchowny KA, Aschmann HE, Chen R, Kiang MV, Mooney AC, Stokes AC, Glymour MM, Bibbins-Domingo K
Impact of Bradyarrhythmias Requiring Pacing on Outcomes in Patients With COVID-19
Authors: Vasti EC MD, MPH; Ashland MD MS, O'Donnell C MD; Rodriguez F MD, MPH; Wang P MD; O'Brien CG MD
The Lancet. Global health
Authors: Tison GH, Barrios J, Avram R, Kuhar P, Bostjancic B, Marcus GM, Pletcher MJ, Olgin JE
